Peer-influenced content. Sources you trust. No registration required. This is HCN.
Gut
Lincosamides carried a 31-fold CDI risk and PPIs nearly doubled it in a Swedish analysis of 42,921 cases and 355,159 controls, with corticosteroids, antidepressants, and beta blockers also emerging as independent contributors.
Clinical Pharmacology April 27th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS